COV-19
Showing 1 - 25 of >10,000
COVID-19, Vaccines Trial in Gyeonggi-do, Incheon, Seoul (AdCLD-CoV19-1 OMI (Part A), AdCLD-CoV19-1 OMI (Part B), Placebo (Part
Recruiting
- COVID-19
- Vaccines
- AdCLD-CoV19-1 OMI (Part A)
- +2 more
-
Gyeonggi-do, Korea, Republic of
- +6 more
Nov 15, 2022
COVID-19, Vaccines Trial in Korea, Republic of (AdCLD-CoV19-1 OMI, Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran))
Not yet recruiting
- COVID-19
- Vaccines
- AdCLD-CoV19-1 OMI
- Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
-
Busan, Korea, Republic of
- +13 more
Aug 15, 2023
Antibody, Vaccine, Maternal Trial in Kuala Lumpur
Completed
- Antibody
- +3 more
-
Kuala Lumpur, W.Persekutuan, MalaysiaUKM Medical Center
Mar 30, 2022
Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine
Completed
- COVID-19 Vaccines
- Hemodialysis Complication
- Evaluation of the immunogenicity of the vaccine in haemodialysis patients
-
Lyon, France
- +1 more
May 4, 2022
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of
Enrolling by invitation
- COVID-19
- +2 more
- Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
-
Kunming, Yunnan, ChinaSheng'Ai Traditional Medicine Hospital
Sep 22, 2023
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Hormonal Contributors to COVID-19 Infection (COV-ENDO)
Active, not recruiting
- COVID-19 Pandemic
- Endocrine System Diseases
- blood testing
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Mar 6, 2023
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive
Not yet recruiting
- COVID-19
- +5 more
- imPulse™ Una infrasound-to-ultrasound e-stethoscope
- (no location specified)
Mar 9, 2023
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)
Recruiting
- SARS-CoV2 Infection
- General SARS-CoV-2 Communication
- Rural-Targeted SARS-CoV-2 Communication
-
Flint, MichiganFlint Journal Building
Oct 10, 2023
Covid19 Trial in Ansan, Suwon, Seoul (AdCLD-CoV19-1)
Active, not recruiting
- Covid19
- AdCLD-CoV19-1
-
Ansan, Province, Korea, Republic of
- +2 more
Jan 21, 2022
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B
Not yet recruiting
- SARS-CoV-2
- +4 more
- LumiraDx SARS-CoV-2 Ag Ultra
- LumiraDx SARS-CoV-2 & Flu A/B
-
DeLand, FloridaHillcrest Medical Research
Feb 6, 2023
COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))
Recruiting
- COVID-19
- SARS-CoV-2 DNA Vaccine (ICCOV)
-
Wong Chuk Hang, Hong KongGleneagles Hospital Hong Kong
Jun 16, 2023
Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:
Completed
- COVID-19
-
Cairo, None Selected, Egyptbalsam Sherif Fahmy
Jul 12, 2023
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)
Terminated
- Covid19
- SARS-COV-2 Infection
- DWJ1248
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Dec 4, 2022
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test
Not yet recruiting
- SARS-CoV-2
- +3 more
- LumiraDx SARS-CoV-2 & Flu A/B
-
Cullman, AlabamaCullman Clinical Trials
Mar 16, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2
Recruiting
- Covid19
- Serologic immunoassays to SARS-CoV-2 antibodies
-
Detroit, MichiganHenry Ford Health System
Dec 13, 2022
Sars-Covid-19 Vaccines in Haematological Patients: Prospective
Completed
- Hematologic Diseases
- IgG antibodies to Sars-Cov-2
- QuantiFERON SARS-CoV-2 test
-
Monza, Lombardia, ItalySan Gerardo Hospital
Jan 23, 2023